# Cato Corp: financial statements, quarterly

CATO · NYSE · CIK 18255 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/cato.md) · [Financials](/companies/cato/financials.md) · [Filings](/companies/cato/filings.md) · [Insiders](/companies/cato/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cato/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [158](/filings/0001562762-24-000277.md) | [175 d](/filings/0001562762-26-000041.md) | [177](/filings/0001562762-25-000149.md) | [169](/filings/0001562762-25-000224.md) | [146](/filings/0001562762-25-000278.md) | [158 d](/filings/0001562762-26-000041.md) | [170](/filings/0000018255-26-000004.md) | [177](/filings/0001562762-26-000100.md) | [155](/filings/0001562762-25-000278.md) | [152 d](/filings/0001562762-26-000041.md) | [171](/filings/0000018255-26-000004.md) | [166](/filings/0001562762-26-000100.md) |
| Cost of revenue | $m | [106](/filings/0001562762-24-000277.md) | [119 d](/filings/0001562762-26-000041.md) | [113](/filings/0001562762-25-000149.md) | [109](/filings/0001562762-25-000224.md) | [103](/filings/0001562762-25-000278.md) | [112 d](/filings/0001562762-26-000041.md) | [109](/filings/0000018255-26-000004.md) | [111](/filings/0001562762-26-000100.md) | [105](/filings/0001562762-25-000278.md) | [106 d](/filings/0001562762-26-000041.md) | [106](/filings/0000018255-26-000004.md) | [110](/filings/0001562762-26-000100.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [61.8](/filings/0001562762-24-000277.md) | [67.4 d](/filings/0001562762-26-000041.md) | [56.8](/filings/0001562762-25-000149.md) | [58.2](/filings/0001562762-25-000224.md) | [57.9](/filings/0001562762-25-000278.md) | [58.6 d](/filings/0001562762-26-000041.md) | [55.3](/filings/0000018255-26-000004.md) | [57.4](/filings/0001562762-26-000100.md) | [57.0](/filings/0001562762-25-000278.md) | [56.7 d](/filings/0001562762-26-000041.md) | [53.9](/filings/0000018255-26-000004.md) | [54.0](/filings/0001562762-26-000100.md) |
| Operating income | $m | [(10.3)](/filings/0001562762-24-000277.md) | [(16.6) d](/filings/0001562762-26-000041.md) | [6.1](/filings/0001562762-25-000149.md) | [(0.6)](/filings/0001562762-25-000224.md) | [(17.0)](/filings/0001562762-25-000278.md) | [(14.9) d](/filings/0001562762-26-000041.md) | [3.4](/filings/0000018255-26-000004.md) | [5.5](/filings/0001562762-26-000100.md) | [(8.2)](/filings/0001562762-25-000278.md) | [(13.5) d](/filings/0001562762-26-000041.md) | [9.0](/filings/0000018255-26-000004.md) | [(0.6)](/filings/0001562762-26-000100.md) |
| Income tax | $m | [(4.3)](/filings/0001562762-24-000277.md) | [10.9 d](/filings/0001562762-26-000041.md) | [0.6](/filings/0001562762-25-000149.md) | [0.6](/filings/0001562762-25-000224.md) | [0.3](/filings/0001562762-25-000278.md) | [0.3 d](/filings/0001562762-26-000041.md) | [0.9](/filings/0000018255-26-000004.md) | [(0.3)](/filings/0001562762-26-000100.md) | [(1.2)](/filings/0001562762-25-000278.md) | [(1.1) d](/filings/0001562762-26-000041.md) | [0.5](/filings/0000018255-26-000004.md) | [0.1](/filings/0001562762-26-000100.md) |
| Net income | $m | [(6.1)](/filings/0001562762-24-000277.md) | [(23.4) d](/filings/0001562762-26-000041.md) | [11.0](/filings/0001562762-25-000278.md) | [0.1](/filings/0001562762-25-000278.md) | [(15.1)](/filings/0001562762-25-000278.md) | [(14.1) d](/filings/0001562762-26-000041.md) | [3.3](/filings/0001562762-26-000100.md) | [6.8](/filings/0001562762-26-000100.md) | [(5.2)](/filings/0001562762-25-000278.md) | [(10.9) d](/filings/0001562762-26-000041.md) | [9.3](/filings/0001562762-26-000100.md) | [1.1](/filings/0001562762-26-000100.md) |
| Diluted EPS | $ per share | [(0.30)](/filings/0001562762-24-000277.md) | not reported | [0.54](/filings/0001562762-25-000149.md) | [0.01](/filings/0001562762-25-000224.md) | [(0.79)](/filings/0001562762-25-000278.md) | not reported | [0.17](/filings/0000018255-26-000004.md) | [0.35](/filings/0001562762-26-000100.md) | [(0.28)](/filings/0001562762-25-000278.md) | not reported | [0.47](/filings/0000018255-26-000004.md) | [0.06](/filings/0001562762-26-000100.md) |
| Basic EPS | $ per share | [(0.30)](/filings/0001562762-24-000277.md) | not reported | [0.54](/filings/0001562762-25-000149.md) | [0.01](/filings/0001562762-25-000224.md) | [(0.79)](/filings/0001562762-25-000278.md) | not reported | [0.17](/filings/0000018255-26-000004.md) | [0.35](/filings/0001562762-26-000100.md) | [(0.28)](/filings/0001562762-25-000278.md) | not reported | [0.47](/filings/0000018255-26-000004.md) | [0.06](/filings/0001562762-26-000100.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.0](/filings/0001562762-23-000429.md) | [23.9](/filings/0001562762-25-000062.md) | [39.1](/filings/0001562762-24-000159.md) | [30.8](/filings/0001562762-24-000215.md) | [20.2](/filings/0001562762-24-000277.md) | [20.3](/filings/0001562762-26-000041.md) | [31.3](/filings/0001562762-25-000149.md) | [34.2](/filings/0001562762-25-000224.md) | [22.8](/filings/0001562762-25-000278.md) | [16.8](/filings/0001562762-26-000100.md) | [25.4](/filings/0000018255-26-000004.md) | [35.1](/filings/0001562762-26-000100.md) |
| Current assets | $m | [261](/filings/0001562762-23-000429.md) | [243](/filings/0001562762-25-000062.md) | [250](/filings/0001562762-24-000159.md) | [243](/filings/0001562762-24-000215.md) | [230](/filings/0001562762-24-000277.md) | [223](/filings/0001562762-26-000041.md) | [226](/filings/0001562762-25-000149.md) | [226](/filings/0001562762-25-000224.md) | [210](/filings/0001562762-25-000278.md) | [193](/filings/0001562762-26-000100.md) | [217](/filings/0000018255-26-000004.md) | [208](/filings/0001562762-26-000100.md) |
| Total assets | $m | [487](/filings/0001562762-23-000429.md) | [487](/filings/0001562762-25-000062.md) | [477](/filings/0001562762-24-000159.md) | [456](/filings/0001562762-24-000215.md) | [424](/filings/0001562762-24-000277.md) | [452](/filings/0001562762-26-000041.md) | [441](/filings/0001562762-25-000149.md) | [437](/filings/0001562762-25-000224.md) | [450](/filings/0001562762-25-000278.md) | [421](/filings/0001562762-26-000100.md) | [439](/filings/0000018255-26-000004.md) | [423](/filings/0001562762-26-000100.md) |
| Current liabilities | $m | [184](/filings/0001562762-23-000429.md) | [188](/filings/0001562762-25-000062.md) | [184](/filings/0001562762-24-000159.md) | [174](/filings/0001562762-24-000215.md) | [170](/filings/0001562762-24-000277.md) | [188](/filings/0001562762-26-000041.md) | [183](/filings/0001562762-25-000149.md) | [175](/filings/0001562762-25-000224.md) | [152](/filings/0001562762-25-000278.md) | [156](/filings/0001562762-26-000100.md) | [168](/filings/0000018255-26-000004.md) | [153](/filings/0001562762-26-000100.md) |
| Shareholders' equity | $m | [217](/filings/0001562762-23-000429.md) | [192](/filings/0001562762-25-000062.md) | [197](/filings/0001562762-24-000159.md) | [195](/filings/0001562762-24-000215.md) | [177](/filings/0001562762-24-000277.md) | [162](/filings/0001562762-26-000041.md) | [165](/filings/0001562762-25-000149.md) | [172](/filings/0001562762-25-000224.md) | [168](/filings/0001562762-25-000278.md) | [157](/filings/0001562762-26-000100.md) | [167](/filings/0000018255-26-000004.md) | [168](/filings/0001562762-26-000100.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(9.9) d](/filings/0001562762-24-000277.md) | [(11.2) d](/filings/0001562762-26-000041.md) | [5.7](/filings/0001562762-25-000149.md) | [3.1 d](/filings/0001562762-25-000224.md) | [(22.1) d](/filings/0001562762-25-000278.md) | [(6.5) d](/filings/0001562762-26-000041.md) | [3.9](/filings/0000018255-26-000004.md) | [11.8 d](/filings/0001562762-26-000100.md) | [(12.4) d](/filings/0001562762-25-000278.md) | [(4.7) d](/filings/0001562762-26-000041.md) | [8.0](/filings/0000018255-26-000004.md) | [14.5 d](/filings/0001562762-26-000100.md) |
| Capital expenditure | $m | [1.8 d](/filings/0001562762-24-000277.md) | [2.3 d](/filings/0001562762-26-000041.md) | [3.3](/filings/0001562762-25-000149.md) | [1.5 d](/filings/0001562762-25-000224.md) | [1.7 d](/filings/0001562762-25-000278.md) | [1.4 d](/filings/0001562762-26-000041.md) | [1.0](/filings/0000018255-26-000004.md) | [1.3 d](/filings/0001562762-26-000100.md) | [0.5 d](/filings/0001562762-25-000278.md) | [0.9 d](/filings/0001562762-26-000041.md) | [1.1](/filings/0000018255-26-000004.md) | [1.3 d](/filings/0001562762-26-000100.md) |
| Dividends paid | $m | [3.5 d](/filings/0001562762-24-000277.md) | [3.5 d](/filings/0001562762-26-000041.md) | [3.5](/filings/0001562762-25-000149.md) | [3.5 d](/filings/0001562762-25-000224.md) | [3.5 d](/filings/0001562762-25-000278.md) | [0.0 d](/filings/0001562762-26-000041.md) | [0.0](/filings/0001562762-25-000149.md) | [0.0 d](/filings/0001562762-25-000224.md) | [0.0 d](/filings/0001562762-25-000278.md) | [0.0 d](/filings/0001562762-26-000041.md) | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0001562762-24-000277.md) | [(0.0) d](/filings/0001562762-26-000041.md) | [2.2](/filings/0001562762-25-000149.md) | [0.0 d](/filings/0001562762-25-000224.md) | [0.2 d](/filings/0001562762-25-000278.md) | [1.5 d](/filings/0001562762-26-000041.md) | [0.9](/filings/0000018255-26-000004.md) | [0.1 d](/filings/0001562762-26-000100.md) | [0.0 d](/filings/0001562762-25-000278.md) | [0.0 d](/filings/0001562762-26-000041.md) | [0.3](/filings/0000018255-26-000004.md) | [0.1 d](/filings/0001562762-26-000100.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.9](/filings/0001562762-23-000429.md) | [19.3](/filings/0001562762-24-000159.md) | [19.4](/filings/0001562762-24-000215.md) | [19.4](/filings/0001562762-24-000277.md) | [19.4](/filings/0001562762-25-000149.md) | [19.3](/filings/0001562762-25-000224.md) | [19.3](/filings/0001562762-25-000278.md) | [18.7](/filings/0000018255-26-000004.md) | [18.8](/filings/0001562762-26-000100.md) | [18.8](/filings/0001562762-25-000278.md) | [18.8](/filings/0000018255-26-000004.md) | [19.0](/filings/0001562762-26-000100.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.